Pure Global
NCT05793944

SmartMom: Teaching by Texting to Promote Health Behaviours in Pregnancy

Teaching by Texting to Promote Health Behaviours in Pregnancy
University of British Columbia·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Pregnancy
Drug/Device/Intervention
SmartMom text messaging
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of British Columbia
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2023
End date
Feb 01, 2026
Enrollment
3078 participants
Primary outcome

Change in weight during pregnancy,Attendance at prenatal care visits through pregnancy

Summary

The goal of this randomized clinical trial is to evaluate the effectiveness of SmartMom, a
 text messaging-based mobile health program for prenatal education. The main questions are to
 determine if healthy pregnant people receiving SmartMom messages that promote health
 behaviours in pregnancy versus messages that don't provoke behaviour change have improvement
 in:
 
 1. knowledge about healthy pregnancy and birth
 
 2. standardized measures of depression, anxiety, and fear of childbirth
 
 3. adoption of positive health behaviours in pregnancy
 
 4. maternal, fetal, and newborn outcomes
 
 Participants in the intervention group will receive three evidence-based text messages per
 week, plus optional supplemental messages on topics relevant to them, throughout pregnancy.
 
 The control group will receive general interest messages on pregnancy-related topics that are
 not promoting behaviour change.

ICD-10 classifications
Pregnancy confirmedPregnancy-related condition, unspecifiedAbdominal pregnancyPregnancy, not (yet) confirmedOvarian pregnancy
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05793944
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05793944 through Pure Global AI's free database. This phase not specified trial is sponsored by University of British Columbia and is currently Not yet recruiting. The study focuses on Pregnancy. Target enrollment is 3078 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.